Key Findings
- Valerian improved subjective sleep quality ratings by 37% compared to placebo (OR = 1.37, 95% CI: 1.05 to 1.78)
- Sleep onset latency showed a non-significant trend toward improvement (WMD = -0.70 min, p = 0.09)
- Effects were dose-dependent with 450-900mg showing the most consistent results
- Benefits were more pronounced after 4-6 weeks of continuous use compared to single-dose administration
- Adverse effects were comparable to placebo, with no reports of morning grogginess at recommended doses